Similarly, the effect of antitumor cytokine TRAIL against pancreatic cancer was controversial [58], probably due to the affinity of wild type TRAIL to five receptors, including decoys DcR1, DcR2, and OPG. This evidence concerns the gene TNFSF10 and familial pancreatic carcinoma.